SimonMed Imaging has announced the nationwide launch of its Personalized Breast Cancer Detection (PBCD) program, expanding its existing AI-enabled breast cancer screening services. The new program will be available as a $40 add-on to standard screening 3D mammograms at SimonMed centers across the United States.
“SimonMed has offered AI technology in all 3D Mammograms to enhance breast cancer detection since 2019. Unlike other imaging centers, we offer this service at no additional cost to patients and will continue to do so,” said Dr. John Simon, CEO and Founder of SimonMed. “With PBCD, we’re taking AI enhanced Mammogram screening a step further by offering patients the option to have a timely, personalized risk assessment that considers each patient’s unique health profile. This comprehensive approach ensures that patients receive tailored recommendations for further screening, empowering them with the right care including ultrasound or MRI based on their individual risk levels. We know adding ultrasound or MRI to AI enhanced mammography with an individualized approach can more than double early detection.”
The PBCD program provides patients with faster results, detailed breast density recommendations, a personal risk assessment, and a tailored action plan for screening cadence and supplemental exams. The service requires no additional radiation exposure or extra time during the mammogram.
“The biggest improvement we have seen with using AI in our screenings is the confidence it brings to both radiologists and patients. AI has become a game-changer, providing significant patient benefits in screenings. Now with PBCD, we can continue to give patients the confidence they deserve in protecting their health,” said Dr. Angela Fried, MD, Director of Women’s Imaging at SimonMed.
SimonMed operates approximately 170 sites across 11 states with over 200 subspecialty-trained radiologists, making it one of the largest outpatient medical imaging providers in the United States.
